Cutting edge: HIV-1 infection induces a selective reduction in STAT5 protein expression

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 28-31

  Pericle, Federica ^a   Pinto, Ligia A ^a   Hicks, Stuart ^a   Kirken, Robert A ^b   Sconocchia, Giuseppe ^a   Rusnak, Janice ^c   Dolan, Matthew J ^c   Shearer, Gene M ^a   Segal, David M ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; STAT5 PROTEIN; DNA BINDING PROTEIN; MILK PROTEIN; STAT5A PROTEIN, HUMAN; STAT5B PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; CELL CULTURE; METABOLISM; SERODIAGNOSIS; VIROLOGY;

CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; HIV INFECTIONS; HUMANS; MILK PROTEINS; PRECIPITIN TESTS; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS;

EID: 0031626513     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. + T helper cell depletion occurs. J. Clin. Invest. 82:1908.
2. Fauci, A. S., G. Pantaleo, S. Stanley, and D. Weissman. 1996. Immunopathogenic mechanisms of HIV infection. Ann. Intern. Med. 124:654.
3. lck in CD4 T cells from HIV-1 infected patients. Int. Immunol. 6:611.
4. lck dissociation. J. Immunol. 154:2996.
5. lck. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:204.
6. Morio, T., T. Chatila, and R. S. Geha. 1997. HIV glycoprotein gp120 inhibits TCR-CD3-mediated activation of fyn and lck. Int. Immunol. 9:53.
7. Phipps, D. J., S. E. Read, J. P. Piovesan, G. B. Mills, and D. R. Branch. 1996. HIV infection in vitro enhances the activity of src-family protein tyrosine kinases. AIDS 10:1191.
8. + lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants. Clin. Exp. Immunol. 104:11.
9. Nokta, M. A., M. I. Hassan, J. A. Morgan, K. A. Loesch, and R. B. Pollard. 1994. Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)-induced cellular hyporesponsiveness. Proc. Soc. Exp. Biol. Med. 207:284.
10. + T lymphocytes. Eur. J. Immunol. 27:397.
11. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575.
12. Romagnani, S. 1996. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 4:470.
13. Klein, S. A., J. M. Dobmeyer, T. S. Dobmeyer, M. Pape, O. G. Ottmann, E. B. Helm, D. Hoelzer, and R. Rossol. 1997. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11:1111.
14. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation:are we there yet? Immunity 7:1.
15. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
16. Darnell, J. E. 1997. STATs and gene regulation. Science 277:1630.
17. Liu, X., G. W. Robinson, F. Gouilleux, B. Groner, and L. Hennighausen. 1995. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA 92:8831.
18. Heim, M. H. 1996. The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus. Eur. J. Clin. Invest. 26:1.
19. Pericle, F., R. A. Kirken, V. Bronte, G. Sconocchia, L. DaSilva, and D. M. Segal. 1997. Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. J. Immunol. 159:2580.
20. Pinto, L. A., J. Sullivan, J. A. Berzofsky, M. Clerici, H. A. Kessler, A. L. Landay, and G. M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867.
21. Blauvelt, A., M. Clerici, D. R. Lucey, S. M. Steinberg, R. Yarchoan, R. Walker, G. M. Shearer, and S. I. Katz. 1995. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J. Immunol. 154:3506.
22. Redfield, R. R., D. C. Wright, and E. C. Tramont. 1986. The Walter Reed staging classification for HTLV-III/LAV infection. N. Engl. J. Med. 314:131.
23. Zolla-Pazner, S., J. O'Leary, S. Burda, M. K. Gorny, M. Kim, J. Mascola, and F. McCutchan. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69:3807.
24. Sakaida, H., T. Murakami, S. Kawamata, T. Hattori, and T. Uchiyama. 1997. V3 loop of human immunodeficiency virus type 1 suppresses interleukin 2-induced T cell growth. AIDS Res. Hum. Retroviruses 13:151.
25. Chirmule, N., and S. Pahwa. 1996. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol. Rev. 60:386.
26. Purvis, S. F., D. L. Georges, T. M. Williams, and M. M. Lederman. 1992. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell. Immunol. 144:32.
27. Blazevic, V., M. Heino, A. Lagerstedt, A. Ranki, and K. J. Krohn. 1996. Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:208.
28. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
29. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51.
30. van't Wout, A. B., N. A. Kootstra, G. A. Mulder-Kampinga, N. Albrecht-van Lent, H. J. Scherpbier, J. Veenstra, K. Boer, R. A. Coutinho, F. Miedema, and H. Schuitemaker. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94:2060.
31. Rosenberg, Z. F., and A. S. Fauci. 1993. Immunology of HIV infection. In Fundamental Immunology, 3rd ed. W. E. Paul, ed. Raven Press, Ltd, New York, p. 1375.